276 related articles for article (PubMed ID: 16791285)
1. Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease.
Koike H; Ishida A; Shimamura M; Mizuno S; Nakamura T; Ogihara T; Kaneda Y; Morishita R
Gene Ther; 2006 Dec; 13(23):1639-44. PubMed ID: 16791285
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
3. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
4. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.
Wang L; Muramatsu S; Lu Y; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Hanazono Y; Kume A; Urano F; Ichinose H; Nagatsu T; Nakano I; Ozawa K
Gene Ther; 2002 Mar; 9(6):381-9. PubMed ID: 11960314
[TBL] [Abstract][Full Text] [Related]
5. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model.
Hayashi K; Nakamura S; Morishita R; Moriguchi A; Aoki M; Matsumoto K; Nakamura T; Kaneda Y; Sakai N; Ogihara T
Gene Ther; 2000 Oct; 7(19):1664-71. PubMed ID: 11083475
[TBL] [Abstract][Full Text] [Related]
6. [Adenovirus mediated vascular endothelial growth factor gene transfer protects dopaminergic neurons in Parkinson's disease: experiment with rats].
Tian YY; Sun SG; Wang JN; Tang CJ; Feng Y; Wang L; Chen XW; Qiao X
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(29):2054-9. PubMed ID: 17064552
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
Mandel RJ; Snyder RO; Leff SE
Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.
Aoki M; Morishita R; Taniyama Y; Kida I; Moriguchi A; Matsumoto K; Nakamura T; Kaneda Y; Higaki J; Ogihara T
Gene Ther; 2000 Mar; 7(5):417-27. PubMed ID: 10694824
[TBL] [Abstract][Full Text] [Related]
9. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model.
Shimamura M; Sato N; Oshima K; Aoki M; Kurinami H; Waguri S; Uchiyama Y; Ogihara T; Kaneda Y; Morishita R
Circulation; 2004 Jan; 109(3):424-31. PubMed ID: 14707023
[TBL] [Abstract][Full Text] [Related]
11. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
[TBL] [Abstract][Full Text] [Related]
12. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons.
Iwakura Y; Piao YS; Mizuno M; Takei N; Kakita A; Takahashi H; Nawa H
J Neurochem; 2005 May; 93(4):974-83. PubMed ID: 15857400
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.
Azuma J; Taniyama Y; Takeya Y; Iekushi K; Aoki M; Dosaka N; Matsumoto K; Nakamura T; Ogihara T; Morishita R
Gene Ther; 2006 Aug; 13(16):1206-13. PubMed ID: 16625244
[TBL] [Abstract][Full Text] [Related]
14. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
[TBL] [Abstract][Full Text] [Related]
15. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.
Taniyama Y; Tachibana K; Hiraoka K; Aoki M; Yamamoto S; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Morishita R
Gene Ther; 2002 Mar; 9(6):372-80. PubMed ID: 11960313
[TBL] [Abstract][Full Text] [Related]
16. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.
Kim YK; Lim HH; Song YK; Lee HH; Lim S; Han SM; Kim CJ
Neurosci Lett; 2005 Aug 12-19; 384(1-2):133-8. PubMed ID: 15893426
[TBL] [Abstract][Full Text] [Related]
17. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons.
Hayashi K; Morishita R; Nakagami H; Yoshimura S; Hara A; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Sakai N
Gene Ther; 2001 Aug; 8(15):1167-73. PubMed ID: 11509947
[TBL] [Abstract][Full Text] [Related]
19. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
[TBL] [Abstract][Full Text] [Related]
20. Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
Do Thi NA; Saillour P; Ferrero L; Paunio T; Mallet J
Gene Ther; 2007 Mar; 14(5):441-50. PubMed ID: 17093508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
